Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Block-replacement Therapy vs Methimazole in Radioiodine Therapy for Hyperthyroidism
NCT00150124Phase 4Completed
- Start
- Jan 2003
- Primary completion
- Dec 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of methimazole and levothyroxine sodium in hyperthyroidism, Graves' disease and toxic nodular goiter (TNG) (2 arms). Primary endpoint: Thyroid function at 1 year. Started Jan 2003; status: completed.
02
Drugs
methimazolelevothyroxine sodium
03
Conditions
hyperthyroidismGraves' diseasetoxic nodular goiter (TNG)
Beyond the preview
Go deeper on NCT00150124.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00150124.